PMID: 6540616Jul 30, 1984Paper

Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy

Brain Research
S L Hartgraves, P H Kelly

Abstract

The present experiments investigate the brain sites involved in the elicitation of catalepsy by cholinergic agonists and neuroleptics. Microinjection of acetylcholine chloride (50 micrograms) in combination with eserine (2.5 micrograms) into the ventral mesencephalic reticular formation (MRF) elicited catalepsy. Microinjection of atropine sulfate (5 micrograms) into the same sites reversed the catalepsy of rats treated with haloperidol (1.5 mg/kg) 2 h earlier, but did not reverse morphine-induced (30 mg/kg, 1 h) catalepsy. Haloperidol (25 micrograms) injected into the nucleus accumbens septi (NAS) resulted in catalepsy as severe as that caused by an identical injection into the caudate nucleus. Catalepsy caused by intraNAS haloperidol occurred with a shorter latency than that resulting from intracaudate haloperidol, and was reversed by systemic scopolamine (0.4 mg/kg). On the basis of these results it is suggested that the ventral MRF is a site for the elicitation of catalepsy by cholinergic agonists and for the reversal of neuroleptic-induced catalepsy by anticholinergics, and that neuroleptic-induced catalepsy involves blockade of dopamine receptors in both the NAS and caudate nucleus.

References

Aug 1, 1976·Canadian Journal of Physiology and Pharmacology·C Erzin-WatersP Seeman
Sep 1, 1978·The Journal of Pharmacy and Pharmacology·B CostallR J Naylor
Jan 1, 1978·European Journal of Pharmacology·K B KofferO Hornykiewicz
Feb 7, 1977·European Journal of Pharmacology·C Ezrin-Waters, P Seeman
Mar 1, 1976·European Journal of Pharmacology·L A BaezR Schein
Dec 1, 1973·The Journal of Pharmacy and Pharmacology·A J Pijnenburg, J M van Rossum
Aug 1, 1967·Archives of Neurology·R C Duvoisin
Jul 1, 1972·European Journal of Pharmacology·K Kuschinsky, O Hornykiewicz
Oct 1, 1969·The Journal of Comparative Neurology·H A Waldron, D G Gwyn
Jan 10, 1982·The Journal of Comparative Neurology·R B Veazey, C M Severin
Jan 1, 1981·Annual Review of Pharmacology and Toxicology·L R Squire, H P Davis
Feb 1, 1981·Pharmacology, Biochemistry, and Behavior·R DunstanK G Lloyd
Mar 15, 1980·The Journal of Comparative Neurology·R B Veazey, C M Severin
Mar 15, 1980·The Journal of Comparative Neurology·R B Veazey, C M Severin

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Neural Transmission. General Section·W KolasiewiczK H Sontag
Jul 3, 1990·European Journal of Pharmacology·K OssowskaS Wolfarth
Nov 1, 1985·Pharmacology, Biochemistry, and Behavior·R E Hruska
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·I UshijimaM Yamada
Jun 19, 1998·Pharmacology, Biochemistry, and Behavior·Z SpeiserS Cohen
Dec 28, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·I UshijimaY Watanabe
Nov 2, 2001·Progress in Neurobiology·W R Klemm
May 24, 2003·Behavioural Processes·Silvânia M.M. VasconcelosGlauce S.B. Viana
Apr 6, 2021·The European Journal of Neuroscience·Isabelle WakuAmanda R de Oliveira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.